02 May 2003
Functional interaction between PARP-2 and TRF2: PARP activity negatively regulates TRF2
F. Dantzer, J. Ame, I. Jaco, I. Schulz, M. Giraud-Panis, M. Blasco, E. Gilson, J. Menissier-de Murcia, G. de Murcia, V. SchreiberMed Sci Monit 2003; 9(1): 20-0 :: ID: 15067
Abstract
The DNA-damage dependent poly(ADP-ribose) polymerase-2 (PARP-2) is together with PARP-1 an active player of the base excision repair process thus defining its key role in genome surveillance and protection [1] Telomeres are specialized DNA-protein structures that protect chromosome ends from being recognized and processed as DNA strand breaks. In mammalian, telomere protection depends on the T2AG3 repeat binding protein TRF2, which has been shown to remodel telomeres into large duplex loops (t-loops) [2,3].We present evidence for the possible involvement of PARP-2 in the maintenance of telomere integrity. We show that PARP-2 physically binds to TRF2 with high affinity. The association of both proteins requires the N-terminal domain of PARP-2 and the myb domain of TRF2. Both partners colocalize at promyelocytic leukemia bodies in immortalized telomerase-negative cells. In addition, our data show that PARP activity regulates the DNA binding activity of TRF2 via both a covalent heteromodification of the dimerization domain of TRF2 and a non covalent binding of poly(ADP-ribose) to the myb domain of TRF2. PARP-2–/– primary cells show normal telomere length as well as normal telomerase activity as compared with wild-type cells but display a spontaneously increased frequency of ends lacking detectable T2 AG3 repeats. Altogether, these results suggest that PARP-2 activity function at telomeres, possibly by modulating t-loop formation in response to DNA damage.References: 1.Schreiber V et al: J Biol Chem, 2002; 277: 23028-23036 2.van Steensel B et al: Cell, 1998; 92: 401-413 3.Griffith JD et al: Cell, 1999; 97: 503-514
Keywords: Poly(ADP-ribose) polymerase-2, TRF2, telomere integrity, cellular response to DNA damage
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952